The driving force behind the conceptualization of in vivo culturing of – McqOptions

MCQOPTIONS

1.	The driving force behind the conceptualization of in vivo culturing of tissues was the limited number of donors available and graft-rejection by the immune system.
A.	True
B.	False
Answer» C.

Discussion

No Comment Found

Related MCQs

Which of the following Tissue Engineering products has been approved by the European Medicines Agency (EMA) as an Advanced Therapy medicinal product (Drug)?
Name one 361 HCT/P which cannot be imported.
_____________ need to register with FDA under Title 21 of Code of Federal Regulations (CFR).
Umbilical cord blood stem cells are an example of 361 HCT/Ps that meet the criteria in Title 21 of CFR part 1271.
Which Act governs the manufacture of HCT/Ps?
Title ______________ constitutes of a comprehensive regulatory Framework for the producers of human cells, tissues, and cellular and tissue-based products (HCT/Ps).
Which is the Competent Authority for tissues and cells in the United Kingdom?
Prosthetic devices are capable of restoring normal function, and the number of organ donors is always way less than required.
The driving force behind the conceptualization of in vivo culturing of tissues was the limited number of donors available and graft-rejection by the immune system.
What is the Goal of Tissue Engineering?